These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3874341)

  • 21. Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment.
    Goldberg RB; Reeves ML; Seigler DE; Ryan EA; Miller N; Hsia SL; Skyler JS
    Acta Diabetol Lat; 1985; 22(2):93-101. PubMed ID: 3907233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of insulin-dependent diabetes on plasma lipoproteins in diabetic pregnancy.
    Knopp RH; Van Allen MI; McNeely M; Walden CE; Plovie B; Shiota K; Brown Z
    J Reprod Med; 1993 Sep; 38(9):703-10. PubMed ID: 8254593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of metabolic control on plasma lipids and lipoproteins in insulin-dependent diabetes in children and adolescents].
    Jos J; Thévenin M; Dumont G; Beyne P
    Diabete Metab; 1985 Jun; 11(3):174-80. PubMed ID: 3928411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus.
    Noutsou M; Georgopoulos A
    J Diabetes Complications; 1999; 13(2):98-104. PubMed ID: 10432174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of indoramin and metoprolol on plasma lipids and lipoproteins.
    Martinez TL; Auriemo CR; Machado AM; Cunha MA; Feres MC; Maldjian S; Wortsman A; Delboni FO
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S76-9. PubMed ID: 2423803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal and fetal serum lipid and lipoprotein concentrations and compositions in type 1 diabetic pregnancy: relationship with maternal glycemic control.
    Merzouk H; Madani S; Korso N; Bouchenak M; Prost J; Belleville J
    J Lab Clin Med; 2000 Dec; 136(6):441-8. PubMed ID: 11128745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein abnormalities in well-treated type II diabetic patients.
    Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
    Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.
    Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A
    Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
    Billingham MS; Milles JJ; Bailey CJ; Hall RA
    Diabetes Res; 1989 May; 11(1):13-20. PubMed ID: 2515931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased levels of HDL-cholesterol and apolipoprotein A-I after intensified insulin therapy for diabetes.
    Wilson DP; Fesmire JD; Endres RK; Blackett PR
    South Med J; 1985 Jun; 78(6):636-8. PubMed ID: 3923627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes.
    Valabhji J; Donovan J; McColl AJ; Schachter M; Richmond W; Elkeles RS
    Diabet Med; 2002 May; 19(5):424-8. PubMed ID: 12027932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus.
    Schernthaner G; Kostner GM; Dieplinger H; Prager R; Mühlhauser I
    Atherosclerosis; 1983 Dec; 49(3):277-93. PubMed ID: 6229255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment.
    Gylling H; Miettinen TA
    Diabetologia; 1994 Aug; 37(8):773-80. PubMed ID: 7988779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
    Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
    Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets.
    Kappelle PJ; Dallinga-Thie GM; Dullaart RP;
    Biochim Biophys Acta; 2010 Jan; 1801(1):89-94. PubMed ID: 19800983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein A-I, A-II, B, C-II, and C-III in children with insulin-dependent diabetes mellitus.
    al Muhtaseb N; al Yousuf A; Bajaj JS
    Pediatrics; 1992 May; 89(5 Pt 1):936-41. PubMed ID: 1579407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.
    Purnell JQ; Marcovina SM; Hokanson JE; Kennedy H; Cleary PA; Steffes MW; Brunzell JD
    Diabetes; 1995 Oct; 44(10):1218-26. PubMed ID: 7556961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.